Reps. Sherrill (D-NJ) and Curtis (R-UT) Introduce Legislation to Modernize Access to Prescribing Information

Jun 02, 2022

AmerisourceBergen is a member of the Alliance to Modernize Prescribing Information (AMPI) – a group of pharmaceutical stakeholders with a common interest in advancing regulatory or legislative reforms to facilitate the dissemination of FDA-approved pharmaceutical labeling information via modern digital platforms.  For more information on the issue, please visit AMPI’s website. 

Annually, congressional appropriations legislation includes language that prevents the U.S. Food and Drug Administration (FDA) from advancing a proposed 2014 regulation that would require pharmaceutical prescribing information (PI) be delivered primarily by digital form instead of paper. As a result, PI continues to be primarily distributed in paper format which is often discarded as unnecessary. The FDA estimates that each year 90 billion pages of prescribing labels are discarded without even being used, and, if they are used, they can be out of date by as much as one year. FDA’s proposed regulation to modernize PI would improve the speed of labeling updates, and thus the speed of patient care delivery; avoid potential negative impact to patients; and reduce hundreds of millions of pounds of unnecessary paper waste discarded each year.

AmerisourceBergen supports H.R. 7559, the Prescription Information Modernization Act, recently introduced in Congress by Representatives Sherrill (D-NJ) and Curtis (R-UT).  H.R. 7559 would authorize the FDA to advance a proposed rule that would allow for prescribing information provided by drug manufacturers to prescribers and pharmacists to be transmitted electronically.  Here is a congressional press release related to the bipartisan legislation which includes the following statement from the American Pharmacists Association:  “This legislation will give pharmacists access to real time updates to reliable and trusted prescription drug information. This is important for managing patients’ medications and contributing to safe medication use”.